Showing results (521-530 of 1,408) with videos related to

Sort By:
Pageof 141
NPJ Parkinson'S Disease|March 28, 2026
O-GlcNAcylation regulates microglial neuroinflammation in Parkinson's diseaseDong Yeol Kim, Sang-Min Kim, Chanhaeng Lee, et al.
NPJ Parkinson'S Disease|April 8, 2026
Braking Parkinson's progression: the hypothetical druggable role of striatal parvalbumin interneuronsQuansheng He, Xuan Wang, Xiaowen Zhang, et al.
NPJ Parkinson'S Disease|May 14, 2026
Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohortsXiaoying Kang, Zechuan Lin, Fatma Zehra Calikusu, et al.
NPJ Parkinson'S Disease|February 23, 2026
APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's diseaseRagasudha Botta, Joseph J Locascio, Rong Ye, et al.
NPJ Parkinson'S Disease|February 25, 2026
Machine learning integration of serial blood biomarkers enhances cognitive decline prediction in early Parkinson's diseaseRaziyeh Mohammadi, Samuel Y E Ng, Jayne Y Tan, et al.
NPJ Parkinson'S Disease|February 26, 2026
Serotonergic cortico-limbic and executive network dysfunction in Parkinson's disease impulse control disorders: a PET-fMRI studyDamiano Terenzi, Elise Metereau, Franck Lamberton, et al.
NPJ Parkinson'S Disease|March 14, 2026
Neuroimaging evidence of microstructural alteration in Parkinson's disease with subjective cognitive declineKaidong Chen, Ruixuan Zhang, Yi Ji, et al.
NPJ Parkinson'S Disease|March 13, 2026
PARK19 truncation mutant Dnajc6 causes lysosomal deficiency-induced upregulation of pathologic α-synuclein and neurodegeneration of substantia nigra dopaminergic cells in PARK19 knockin miceHung-Li Wang, Ying-Ling Chen, Tai-Ju Chiu, et al.
NPJ Parkinson'S Disease|February 13, 2026
Neuromelanin imaging outperforms free water imaging in diagnosing early Parkinson's disease: a comparative MRI studyYun Hwa Roh, Jinyoung Youn, Sang-Young Kim, et al.
NPJ Parkinson'S Disease|March 3, 2026
Ultra-performance liquid chromatography-mass spectrometry analysis of post-mortem brain tissue reveals specific amino acid profile dysregulation in Parkinson's disease and Alzheimer's disease patientsJacopo Gervasoni, Anna Di Maio, Marcello Serra, et al.
Pageof 141